ABI2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.155800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.278800E-01
Normal-vs-Stage2
8.995200E-01
Normal-vs-Stage3
7.952200E-02
Normal-vs-Stage4
4.264600E-01
Stage1-vs-Stage2
6.398600E-01
Stage1-vs-Stage3
4.107600E-02
Stage1-vs-Stage4
6.883400E-01
Stage2-vs-Stage3
6.646300E-02
Stage2-vs-Stage4
4.093800E-01
Stage3-vs-Stage4
3.499600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.149800E-01
Normal-vs-AfricanAmerican
4.862600E-01
Normal-vs-Asian
7.378400E-01
Caucasian-vs-AfricanAmerican
4.990000E-01
Caucasian-vs-Asian
3.230200E-01
AfricanAmerican-vs-Asian
1.901610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.199600E-01
Normal-vs-Female
8.097400E-01
Male-vs-Female
9.779400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.575200E-01
Normal-vs-Age(41-60Yrs)
3.182400E-01
Normal-vs-Age(61-80Yrs)
9.707400E-01
Normal-vs-Age(81-100Yrs)
1.606440E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.235500E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.695500E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.172400E-04
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.988200E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.59745999999128E-05
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.515960E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.734600E-01
Normal-vs-Daily Drinker
5.688800E-01
Normal-vs-Weekly Drinker
9.227600E-01
Normal-vs-Occasional Drinker
4.765400E-01
Normal-vs-Social Drinker
4.734200E-01
Non Drinker-vs-Daily Drinker
9.911600E-01
Non Drinker-vs-Weekly Drinker
3.460600E-01
Non Drinker-vs-Occasional Drinker
2.038400E-02
Non Drinker-vs-Social Drinker
2.222100E-02
Daily Drinker-vs-Weekly Drinker
2.917000E-01
Daily Drinker-vs-Occasional Drinker
2.557900E-02
Daily Drinker-vs-Social Drinker
4.166100E-02
Weekly Drinker-vs-Occasional Drinker
2.499400E-01
Weekly Drinker-vs-Social Drinker
2.348000E-01
Occasional Drinker-vs-Social Drinker
8.771800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.125600E-01
Normal-vs-Grade 2
3.043600E-02
Normal-vs-Grade 3
4.397800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.175600E-01
Grade 1-vs-Grade 3
8.919800E-01
Grade 1-vs-Grade 4
2.125600E-01
Grade 2-vs-Grade 3
6.773600E-01
Grade 2-vs-Grade 4
3.043600E-02
Grade 3-vs-Grade 4
4.397800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.820000E-01
Normal-vs-NonDiabetic
7.788400E-01
Diabetic-vs-NonDiabetic
6.565900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.276600E-01
Normal-vs-NoPancreatitis
8.672600E-01
Pancreatitis-vs-NoPancreatitis
8.331800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.735200E-01
Normal-vs-N1
8.748400E-01
N0-vs-N1
4.952000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.776600E-01
Normal-vs-TP53-NonMutant
7.545800E-01
TP53-Mutant-vs-TP53-NonMutant
6.338200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
